Incorporating truncating variants in PALB2, CHEK2 and ATM into the BOADICEA breast cancer risk model

Prediction of Breast Cancer Risk Based on Profiling With Common Genetic Variants

(2015) Nasim Mavaddat et al.   JNCI-Journal of the National Cancer Institute

Clinical outcomes in women with breast cancer and a PALB2 mutation: a prospective cohort analysis

(2015) Cezary Cybulski et al.   LANCET ONCOLOGY

Loss-of-function variants in ATM confer risk of gastric cancer

(2015) Hannes Helgason et al.   NATURE GENETICS

Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer

(2015) Kyriaki Michailidou et al.   NATURE GENETICS

Gene-Panel Sequencing and the Prediction of Breast-Cancer Risk

(2015) Douglas F. Easton et al.   NEW ENGLAND JOURNAL OF MEDICINE

Development of cancer genetic services in the UK: A national consultation

(2015) Ingrid Slade et al.   Genome Medicine

Prediction of Breast Cancer Risk Based on Profiling With Common Genetic Variants

(2015) Nasim Mavaddat et al.   JNCI-Journal of the National Cancer Institute

Frequency of mutations in individuals with breast cancer referred forBRCA1andBRCA2testing using next-generation sequencing with a 25-gene panel

(2014) Nadine Tung et al.   CANCER

Multigene Panel Testing: Planning the Next Generation of Research Studies in Clinical Cancer Genetics

(2014) Mark Robson   JOURNAL OF CLINICAL ONCOLOGY

Clinical Evaluation of a Multiple-Gene Sequencing Panel for Hereditary Cancer Risk Assessment

(2014) Allison W. Kurian et al.   JOURNAL OF CLINICAL ONCOLOGY

Breast-Cancer Risk in Families with Mutations in PALB2

(2014) Antonis C. Antoniou et al.   NEW ENGLAND JOURNAL OF MEDICINE

BOADICEA breast cancer risk prediction model: updates to cancer incidences, tumour pathology and web interface

(2013) A J Lee et al.   BRITISH JOURNAL OF CANCER

Evaluating the performance of the breast cancer genetic risk models BOADICEA, IBIS, BRCAPRO and Claus for predictingBRCA1/2mutation carrier probabilities: a study based on 7352 families from the German Hereditary Breast and Ovarian Cancer Consortium

(2013) Christine Fischer et al.   JOURNAL OF MEDICAL GENETICS

Large-scale genotyping identifies 41 new loci associated with breast cancer risk

(2013) Kyriaki Michailidou et al.   NATURE GENETICS

Hereditary Breast Cancer: The Era of New Susceptibility Genes

(2013) Paraskevi Apostolou et al.   Biomed Research International

CHEK2*1100delC Heterozygosity in Women With Breast Cancer Associated With Early Death, Breast Cancer–Specific Death, and Increased Risk of a Second Breast Cancer

(2012) Maren Weischer et al.   JOURNAL OF CLINICAL ONCOLOGY

Prospective study of breast cancer risk for mutation negative women from BRCA1 or BRCA2 mutation positive families

(2011) S. L. Harvey et al.   BREAST CANCER RESEARCH AND TREATMENT

Gene–gene interactions in breast cancer susceptibility

(2011) Clare Turnbull et al.   HUMAN MOLECULAR GENETICS

Breast Cancer Risk for Noncarriers of Family-SpecificBRCA1andBRCA2Mutations: Findings From the Breast Cancer Family Registry

(2011) Allison W. Kurian et al.   JOURNAL OF CLINICAL ONCOLOGY

No evidence of excess breast cancer risk among mutation-negative women from BRCA mutation-positive families

(2010) Larissa A. Korde et al.   BREAST CANCER RESEARCH AND TREATMENT

Rare, Evolutionarily Unlikely Missense Substitutions in ATM Confer Increased Risk of Breast Cancer

(2009) Sean V. Tavtigian et al.   AMERICAN JOURNAL OF HUMAN GENETICS

Breast cancer risks in individuals testing negative for a known family mutation in BRCA1 or BRCA2

(2009) S. M. Domchek et al.   BREAST CANCER RESEARCH AND TREATMENT

Family History, Genetic Testing, and Clinical Risk Prediction: Pooled Analysis of CHEK2*1100delC in 1,828 Bilateral Breast Cancers and 7,030 Controls

(2009) O. Fletcher et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

The BOADICEA model of genetic susceptibility to breast and ovarian cancers: updates and extensions

(2008) A C Antoniou et al.   BRITISH JOURNAL OF CANCER

CHEK2*1100delC Genotyping for Clinical Assessment of Breast Cancer Risk: Meta-Analyses of 26,000 Patient Cases and 27,000 Controls

(2008) Maren Weischer et al.   JOURNAL OF CLINICAL ONCOLOGY